Snowball logo
logo
3000

Chongqing Lummy Pharmaceutical

300006 SHE
¥5.37¥0.00  (0%)
Estimate
EPS
-0.13
Beta
0.327
Growth
Revenue, YoY
-8.16%
Net income, YoY
-8.98%
FCF, YoY
24.79%
About the company
Ticker
300006
ISIN
CNE100000H10
Country
China
Sector (GICS)
Healthcare
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.

Frequently asked questions

What sector does Chongqing Lummy Pharmaceutical (300006) operate in?

Chongqing Lummy Pharmaceutical belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Chongqing Lummy Pharmaceutical (300006) current stock price?

As of the latest data, Chongqing Lummy Pharmaceutical stock price is CN¥5.37, with a previous close of CN¥5.37.

What is Chongqing Lummy Pharmaceutical (300006) current market capitalization?

Chongqing Lummy Pharmaceutical market cap is approximately 5.67 billion.

What is Chongqing Lummy Pharmaceutical (300006) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.13.

Does Chongqing Lummy Pharmaceutical (300006) pay dividends?

No. Chongqing Lummy Pharmaceutical does not pay a dividend.

What is Chongqing Lummy Pharmaceutical (300006) beta (volatility) score?

Chongqing Lummy Pharmaceutical has a beta of 0.327, indicating lower volatility than the overall market.